Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs GSK✓SelectedUSD · GSKMRNA vs GSK performance historyLatest closeAs of-4.84%11/18
Stock and ETF performance explorer

MRNA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-21.7%
GSK return
+42.7%
Excess return
-64.4%
Maximum drawdown
-93.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.8%-1.3%-3.5%-3.8%
7D-20.9%-3.1%-17.7%-18.9%
30D-13.3%-0.9%-12.4%-12.9%
3M+212.6%-4.2%+216.7%+229.0%
6M+309.0%-1.6%+310.6%+323.3%
YTD+567.3%+2.6%+564.7%+571.7%
1Y+689.7%+6.2%+683.5%+681.1%
3Y+157.4%+55.0%+102.5%+109.6%
5Y-21.7%+42.8%-64.6%-19.6%
All-21.7%+42.7%-64.4%-19.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling